Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
Mindset Pharma is set to participate in Stifel GMP’s Future of Healthcare Conference on December 8, 2021. The company focuses on developing next-generation psychedelic medicines designed to address significant neurological and psychiatric disorders. CEO James Lanthier and CSO Joseph Araujo will present live at 1:00 p.m. ET. Interested parties can register for the event through the company's website. Mindset is exploring novel psychedelic compounds and processes, including the synthesis of psilocybin, to fulfill unmet medical needs.
- None.
- None.
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it will participate in Stifel GMP’s The Future of Healthcare Conference to be held virtually on Wednesday, December 8, 2021.
James Lanthier, CEO of Mindset, and Joseph Araujo, CSO of Mindset, will present live at 1:00 p.m. ET. Register to attend here.
For more information about the conference, or to schedule a one-on-one meeting with Mindset's management team, please contact your appropriate Stifel GMP representative directly, or send an email to KCSA Strategic Communications at MindSet@kcsa.com.
About Mindset Pharma
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds.
For further information on Mindset, please visit our website at www.mindsetpharma.com.
For more information, please contact:
Investor Contact:
Allison Soss/Tim Regan
KCSA Strategic Communications
Email: MindSet@kcsa.com
Phone: 212-896-1267/ 347-487-6788
Company Contact:
James Lanthier, CEO
Email: jlanthier@mindsetpharma.com
Jason Atkinson, VP, Corporate Development
Email: jatkinson@mindsetpharma.com
Phone: 416-479-4094
Forward-Looking Information
This news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward looking information is frequently characterized bywords such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Additional information regarding risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form for the financial year ended June 30, 2020 dated March 5, 2021. The forward-looking information included in this news release is made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise, except as required by applicable law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FAQ
What is Mindset Pharma's stock symbol?
When will Mindset Pharma present at the Future of Healthcare Conference?
Who will represent Mindset Pharma at the conference?
What is the focus of Mindset Pharma's drug development?
How can I register for the Stifel GMP conference?
